IS5260A - Uppleystar sertralín samsetningar - Google Patents
Uppleystar sertralín samsetningarInfo
- Publication number
- IS5260A IS5260A IS5260A IS5260A IS5260A IS 5260 A IS5260 A IS 5260A IS 5260 A IS5260 A IS 5260A IS 5260 A IS5260 A IS 5260A IS 5260 A IS5260 A IS 5260A
- Authority
- IS
- Iceland
- Prior art keywords
- formulations
- dissolved sertraline
- sertraline
- dissolved
- sertraline formulations
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
- A61K9/0004—Osmotic delivery systems; Sustained release driven by osmosis, thermal energy or gas
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2009—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2013—Organic compounds, e.g. phospholipids, fats
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/02—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/12—Carboxylic acids; Salts or anhydrides thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
- A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
- A61K47/183—Amino acids, e.g. glycine, EDTA or aspartame
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US5141397P | 1997-07-01 | 1997-07-01 | |
| PCT/IB1998/000933 WO1999001120A1 (en) | 1997-07-01 | 1998-06-15 | Solubilized sertraline compositions |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IS5260A true IS5260A (is) | 1999-11-19 |
Family
ID=21971159
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IS5260A IS5260A (is) | 1997-07-01 | 1999-11-19 | Uppleystar sertralín samsetningar |
Country Status (34)
| Country | Link |
|---|---|
| EP (1) | EP0999829A1 (ko) |
| JP (1) | JP2000514100A (ko) |
| KR (1) | KR100366373B1 (ko) |
| CN (1) | CN1261794A (ko) |
| AP (1) | AP1192A (ko) |
| AR (3) | AR015917A1 (ko) |
| AU (1) | AU742535B2 (ko) |
| BG (1) | BG103918A (ko) |
| BR (1) | BR9810739A (ko) |
| CA (1) | CA2290974C (ko) |
| CO (1) | CO4940495A1 (ko) |
| DZ (1) | DZ2548A1 (ko) |
| EA (1) | EA002481B1 (ko) |
| HN (1) | HN1998000102A (ko) |
| HR (1) | HRP980377A2 (ko) |
| HU (1) | HUP0002236A3 (ko) |
| ID (1) | ID23429A (ko) |
| IL (1) | IL133076A (ko) |
| IS (1) | IS5260A (ko) |
| MA (1) | MA24587A1 (ko) |
| NO (1) | NO996520L (ko) |
| OA (1) | OA11243A (ko) |
| PA (1) | PA8454301A1 (ko) |
| PE (1) | PE97199A1 (ko) |
| PL (1) | PL337804A1 (ko) |
| SK (1) | SK181099A3 (ko) |
| TN (1) | TNSN98124A1 (ko) |
| TR (1) | TR199903297T2 (ko) |
| TW (1) | TW550087B (ko) |
| UA (1) | UA67741C2 (ko) |
| UY (1) | UY25071A1 (ko) |
| WO (1) | WO1999001120A1 (ko) |
| YU (1) | YU68299A (ko) |
| ZA (1) | ZA985708B (ko) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AP2002002552A0 (en) | 1999-12-23 | 2002-06-30 | Pfizer Prod Inc | Pharmaceutical compositions providing enhanced drug concentrations. |
| US20030086972A1 (en) * | 2000-08-09 | 2003-05-08 | Appel Leah E. | Hydrogel-driven drug dosage form |
| BR0113626A (pt) | 2000-08-30 | 2003-06-17 | Pfizer Prod Inc | Formulações de liberação sustentada para secretores de hormÈnio do crescimento |
| US20040191207A1 (en) * | 2003-03-31 | 2004-09-30 | Lipari John M. | Alpha-hydroxy acid ester drug delivery compositions and methods of use |
| WO2008110268A1 (en) * | 2007-03-12 | 2008-09-18 | Dsm Ip Assets B.V. | Cosmetic compositions |
| KR20120116422A (ko) * | 2009-12-29 | 2012-10-22 | 코와 가부시키가이샤 | 경구 투여용 의약 조성물 |
| EP2520299A1 (en) * | 2009-12-29 | 2012-11-07 | Kowa Co., Ltd. | Solid pharmaceutical composition for oral administration |
| CN109908354A (zh) * | 2017-12-12 | 2019-06-21 | 万特制药(海南)有限公司 | 盐酸舍曲林口服浓缩液及其制备工艺 |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4803076A (en) * | 1986-09-04 | 1989-02-07 | Pfizer Inc. | Controlled release device for an active substance |
| ATE96999T1 (de) * | 1989-08-30 | 1993-11-15 | Pfizer | Verwendung von sertralin zur behandlung von abhaengigkeiten von chemischen stoffen. |
| ZA97976B (en) * | 1996-04-05 | 1997-08-18 | Alza Corp | Uniform drug delivery theraphy. |
-
1998
- 1998-06-15 JP JP11506774A patent/JP2000514100A/ja active Pending
- 1998-06-15 ID IDW991701A patent/ID23429A/id unknown
- 1998-06-15 IL IL13307698A patent/IL133076A/xx not_active IP Right Cessation
- 1998-06-15 AU AU75448/98A patent/AU742535B2/en not_active Ceased
- 1998-06-15 WO PCT/IB1998/000933 patent/WO1999001120A1/en not_active Application Discontinuation
- 1998-06-15 EP EP98923019A patent/EP0999829A1/en not_active Withdrawn
- 1998-06-15 TR TR1999/03297T patent/TR199903297T2/xx unknown
- 1998-06-15 SK SK1810-99A patent/SK181099A3/sk unknown
- 1998-06-15 YU YU68299A patent/YU68299A/sh unknown
- 1998-06-15 KR KR10-1999-7011361A patent/KR100366373B1/ko not_active IP Right Cessation
- 1998-06-15 CN CN98806763A patent/CN1261794A/zh active Pending
- 1998-06-15 UA UA99116391A patent/UA67741C2/uk unknown
- 1998-06-15 CA CA002290974A patent/CA2290974C/en not_active Expired - Fee Related
- 1998-06-15 BR BR9810739-9A patent/BR9810739A/pt not_active Application Discontinuation
- 1998-06-15 PL PL98337804A patent/PL337804A1/xx unknown
- 1998-06-15 HU HU0002236A patent/HUP0002236A3/hu unknown
- 1998-06-15 EA EA199900962A patent/EA002481B1/ru unknown
- 1998-06-25 AP APAP/P/1998/001280A patent/AP1192A/en active
- 1998-06-25 TW TW087110267A patent/TW550087B/zh active
- 1998-06-26 PE PE1998000573A patent/PE97199A1/es not_active Application Discontinuation
- 1998-06-29 UY UY25071A patent/UY25071A1/es not_active IP Right Cessation
- 1998-06-29 PA PA19988454301A patent/PA8454301A1/es unknown
- 1998-06-29 AR ARP980103146A patent/AR015917A1/es not_active Application Discontinuation
- 1998-06-30 DZ DZ980158A patent/DZ2548A1/xx active
- 1998-06-30 TN TNTNSN98124A patent/TNSN98124A1/fr unknown
- 1998-06-30 MA MA25146A patent/MA24587A1/fr unknown
- 1998-06-30 ZA ZA9805708A patent/ZA985708B/xx unknown
- 1998-07-01 CO CO98037137A patent/CO4940495A1/es unknown
- 1998-07-01 HR HR60/051,413A patent/HRP980377A2/hr not_active Application Discontinuation
- 1998-07-01 HN HN1998000102A patent/HN1998000102A/es unknown
-
1999
- 1999-11-19 IS IS5260A patent/IS5260A/is unknown
- 1999-11-23 BG BG103918A patent/BG103918A/xx unknown
- 1999-12-21 OA OA9900301A patent/OA11243A/en unknown
- 1999-12-28 NO NO996520A patent/NO996520L/no not_active Application Discontinuation
-
2003
- 2003-06-19 AR ARP030102180A patent/AR040280A2/es unknown
- 2003-06-19 AR ARP030102179A patent/AR040279A2/es unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MA24473A1 (fr) | Formulations | |
| IS5555A (is) | Selekoxib lyfjablöndur | |
| ID30031A (id) | Formulasi-formulasi agrokimia | |
| ID23546A (id) | Formulasi-formulasi ziprasidon | |
| NO20004240D0 (no) | Formuleringer | |
| ATE224703T1 (de) | Brauseformulierungen | |
| DE59802860D1 (de) | Desinfektionsmittel | |
| DK0853945T3 (da) | Flydende gonadotropinholdige formuleringer | |
| NO20001631L (no) | 2-metyl-tieno-benzodiazepin formulering | |
| ID23299A (id) | Formulasi-formulasi farmasi | |
| PT1130966E (pt) | Formulacoes antiparasitarias | |
| DE69828330D1 (de) | Aktiviertes Protein C Formulierungen | |
| DE69812475T2 (de) | Photoresistzusammensetzung | |
| ATE227074T1 (de) | Mikrokapsel-formulierungen | |
| CY2006006I2 (el) | Πρωτεϊνικα σκευασματα | |
| NO980546D0 (no) | Farmasöytiske midler | |
| DE69809717T2 (de) | Konzentrierte desinfektionsmittel | |
| DE69935609D1 (de) | Formulierungen enthaltend cefuroxim-axetil | |
| ATE232683T1 (de) | Mikrokapsel-formulierungen | |
| DE69800779T2 (de) | Photopolymerisierbare Zusammensetzung | |
| DE69809633D1 (de) | Photoresistzusammensetzung | |
| NO995147D0 (no) | Kontrastmidler | |
| NO20002590D0 (no) | Formuleringer omfattende oppløst paroxetin | |
| IS5260A (is) | Uppleystar sertralín samsetningar | |
| EE9900594A (et) | Uued astmavastased ravimkoostised |